|
|
||||||||||||||
|
|
|||||||||||||||
COELIAC DISEASE |
1 Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
2 Department of Pathology, Lund University Hospital, Lund, Sweden
3 Department of Paediatrics, Astrid Lindgrens Childrens Hospital, Stockholm, Sweden
4 Department of Oncology, Radiology, and Clinical Immunology, Uppsala University Hospital and Department of Oncology and Pathology, Karolinska Hospital, Stockholm, Sweden
5 Department of Medicine, Clinical Epidemiology Unit, Karolinska Hospital, Stockholm, Sweden
6 Department of Medicine, Clinical Epidemiology Unit, and Department of Medicine, Rheumatology Unit, Karolinska Hospital, Stockholm, Sweden
Correspondence to:
Correspondence to:
Dr K E Smedby
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Box 281, SE-171 77 Stockholm, Sweden; karin.ekstrom{at}meb.ki.se
Background: Numerous studies have reported on the association between coeliac disease and the otherwise uncommon enteropathy-type T cell lymphoma (ETTL). A systematic risk assessment of more prevalent lymphoma entities, such as B cell and non-intestinal lymphomas, in coeliac disease has not been performed.
Aims: In light of the increasing number of patients diagnosed with coeliac disease and the unknown aetiology of malignant lymphomas, we aimed to estimate the distribution and risk of lymphoma subtypes in coeliac disease.
Methods: We reviewed and reclassified 56 cases of incident malignant lymphomas occurring in a Swedish population based cohort of 11 650 patients hospitalised with coeliac disease. The observed numbers of lymphoma subtypes were compared with those expected in the Swedish population.
Results: The majority (n = 32, 57%) of lymphomas in the cohort were not intestinal T cell lymphomas. Significantly increased risks were observed for B cell non-Hodgkin lymphoma (NHL) (standardised incidence ratio (SIR) 2.2 (95% confidence interval (CI) 1.23.6); 11 non-intestinal and five intestinal) and for lymphomas of non-intestinal origin (SIR 3.6 (95% CI 2.35.2), 11 B and 14 T cell). Furthermore, 44% of patients with B cell NHL had a history of other autoimmune/inflammatory diseases. The relative risks for T cell NHL (SIR 51 (95% CI 3568); n = 37) and for primary gastrointestinal lymphomas (SIR 24 (95% CI 1634); five B and 25 T cell) were markedly increased, as anticipated.
Conclusion: Most lymphomas complicating coeliac disease are indeed related to the disease and are not of the ETTL-type. There was a remarkable aggregation of autoimmune/inflammatory disorders, female sex, coeliac disease, and B cell lymphoma.
Abbreviations: ETTL, enteropathy-type T cell lymphoma; HL, Hodgkin lymphoma; ICD, International Classification of Diseases; MALT, mucosa associated lymphoid tissue; NHL, non-Hodgkin lymphoma; SIR, standardised incidence ratio; UNS, unspecified; OR, odds ratio
Keywords: coeliac disease; B cell lymphoma; non-intestinal lymphoma; autoimmunity
This article has been cited by other articles:
![]() |
P. Elfstrom, S. M. Montgomery, O. Kampe, A. Ekbom, and J. F. Ludvigsson Risk of Thyroid Disease in Individuals with Celiac Disease J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 3915 - 3921. [Abstract] [Full Text] [PDF] |
||||
![]() |
J F Ludvigsson, O Olen, M Bell, A Ekbom, and S M Montgomery Coeliac disease and risk of sepsis Gut, August 1, 2008; 57(8): 1074 - 1080. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ekstrom Smedby, C. M. Vajdic, M. Falster, E. A. Engels, O. Martinez-Maza, J. Turner, H. Hjalgrim, P. Vineis, A. Seniori Costantini, P. M. Bracci, et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium Blood, April 15, 2008; 111(8): 4029 - 4038. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H.R. Green and C. Cellier Celiac Disease N. Engl. J. Med., October 25, 2007; 357(17): 1731 - 1743. [Full Text] [PDF] |
||||
![]() |
T. Matysiak-Budnik, G. Malamut, N. P.-M. de Serre, E. Grosdidier, S. Seguier, N. Brousse, S. Caillat-Zucman, N. Cerf-Bensussan, J. Schmitz, and C. Cellier Long-term follow-up of 61 coeliac patients diagnosed in childhood: evolution toward latency is possible on a normal diet Gut, October 1, 2007; 56(10): 1379 - 1386. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Elfstrom, S. M. Montgomery, O. Kampe, A. Ekbom, and J. F. Ludvigsson Risk of Primary Adrenal Insufficiency in Patients with Celiac Disease J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3595 - 3598. [Abstract] [Full Text] [PDF] |
||||
![]() |
J F Ludvigsson, U de Faire, A Ekbom, and S M Montgomery Vascular disease in a population-based cohort of individuals hospitalised with coeliac disease Heart, September 1, 2007; 93(9): 1111 - 1115. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ghai, J. Pattison, S. Ghai, M. E. O'Malley, K. Khalili, and M. Stephens Primary Gastrointestinal Lymphoma: Spectrum of Imaging Findings with Pathologic Correlation RadioGraphics, September 1, 2007; 27(5): 1371 - 1388. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Grulich, C. M. Vajdic, and W. Cozen Altered Immunity as a Risk Factor for Non-Hodgkin Lymphoma Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 405 - 408. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Halfdanarson, M. R. Litzow, and J. A. Murray Hematologic manifestations of celiac disease Blood, January 15, 2007; 109(2): 412 - 421. [Abstract] [Full Text] [PDF] |
||||
![]() |
J F Ludvigsson, J Wahlstrom, J Grunewald, A Ekbom, and S M Montgomery Coeliac disease and risk of tuberculosis: a population based cohort study Thorax, January 1, 2007; 62(1): 23 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T. Chang, K. M. Balter, A. Torrang, K. E. Smedby, M. Melbye, C. Sundstrom, B. Glimelius, and H.-O. Adami Nutrient Intake and Risk of Non-Hodgkin's Lymphoma Am. J. Epidemiol., December 15, 2006; 164(12): 1222 - 1232. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Smedby, E. Baecklund, and J. Askling Malignant Lymphomas in Autoimmunity and Inflammation: A Review of Risks, Risk Factors, and Lymphoma Characteristics. Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2069 - 2077. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Ludvigsson, J. Ludvigsson, A. Ekbom, and S. M. Montgomery Celiac Disease and Risk of Subsequent Type 1 Diabetes: A general population cohort study of children and adolescents. Diabetes Care, November 1, 2006; 29(11): 2483 - 2488. [Abstract] [Full Text] [PDF] |
||||
![]() |
C J R Goddard and H R Gillett Complications of coeliac disease: are all patients at risk? Postgrad. Med. J., November 1, 2006; 82(973): 705 - 712. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Askling, L Klareskog, P Blomqvist, M Fored, and N Feltelius Risk for malignant lymphoma in ankylosing spondylitis: a nationwide Swedish case-control study Ann Rheum Dis, September 1, 2006; 65(9): 1184 - 1187. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Ludvigsson, S. M. Montgomery, O. Olen, A. Ekbom, J. Ludvigsson, and M. Fored Coeliac disease and risk of renal disease--a general population cohort study Nephrol. Dial. Transplant., July 1, 2006; 21(7): 1809 - 1815. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Barker Type 1 Diabetes-Associated Autoimmunity: Natural History, Genetic Associations, and Screening J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1210 - 1217. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Smedby, H. Hjalgrim, J. Askling, E. T. Chang, H. Gregersen, A. Porwit-MacDonald, C. Sundstrom, M. Akerman, M. Melbye, B. Glimelius, et al. Autoimmune and Chronic Inflammatory Disorders and Risk of Non-Hodgkin Lymphoma by Subtype J Natl Cancer Inst, January 4, 2006; 98(1): 51 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T. Chang, K. E. Smedby, H. Hjalgrim, C. Schollkopf, A. Porwit-MacDonald, C. Sundstrom, E. Tani, F. d'Amore, M. Melbye, H.-O. Adami, et al. Medication Use and Risk of Non-Hodgkin's Lymphoma Am. J. Epidemiol., November 15, 2005; 162(10): 965 - 974. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |